Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Rojas (Pittsburgh, United States of America). Mesenchymal stem cells and fibrotic lung diseases. International Congress 2014 – Targeting lung fibrosis: from bench to bedside

Member's Comments

No comment yet.

Related content which might interest you: Mesenchymal stem cells in aging and IPF Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research Year: 2016 Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Mesenchymal stem cell therapy for severe emphysema Source: Virtual Congress 2021 – Repair and regeneration in chronic lung disease and lung cancer Year: 2021 Mesenchymal stem cell therapy for severe emphysema Source: ERS Lung Science Conference 2021 Year: 2021 Mesenchymal lineage formation in the lung during development and disease Source: International Congress 2017 – Molecular pathways in lung development Year: 2017 Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Mesenchymal cells, immune cells and the lung stem cell niche Source: Eur Respir Monogr 2021; 91: 134-143 Year: 2021 Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009 Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 YI05 - Mesenchymal stromal cells identified in tissue from lung-transplanted patients Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration Year: 2012 Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease Source: ERS Lung Science Conference 2017 Year: 2017 Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 205-221 Year: 2021 Epithelial mesenchymal transition in lung allografts Source: Eur Respir J 2004; 24: Suppl. 48, 180s Year: 2004 Modelling human lung development and disease using pluripotent stem cells Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats Year: 2015 Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 190-204 Year: 2021 Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis Source: Eur Respir Monogr 2021; 91: 290-305 Year: 2021 Mechanical programming of mesenchymal stromal cells to treat lung fibrosis Source: ERS Lung Science Conference 2018 Year: 2018 Identification of mesenchymal stromal cells in lung tissue from lung-transplanted patients Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019